Osteopore Past Earnings Performance

Past criteria checks 0/6

Osteopore's earnings have been declining at an average annual rate of -19.3%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 27.4% per year.

Key information

-19.3%

Earnings growth rate

14.8%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate27.4%
Return on equity-194.7%
Net Margin-130.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

We Think Osteopore (ASX:OSX) Needs To Drive Business Growth Carefully

Aug 24
We Think Osteopore (ASX:OSX) Needs To Drive Business Growth Carefully

How Many Osteopore Limited (ASX:OSX) Shares Have Insiders Sold, In The Last Year?

Dec 29
How Many Osteopore Limited (ASX:OSX) Shares Have Insiders Sold, In The Last Year?

Revenue & Expenses Breakdown

How Osteopore makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:OSX Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 243-441
31 Mar 242-441
31 Dec 232-552
30 Sep 232-552
30 Jun 232-552
31 Mar 232-541
31 Dec 222-441
30 Sep 222-441
30 Jun 221-441
31 Mar 221-450
31 Dec 211-450
30 Sep 211-340
30 Jun 211-340
31 Mar 211-240
31 Dec 202-240
30 Sep 201-230
30 Jun 201-230
31 Mar 201-230
31 Dec 190-230
31 Dec 181-120
31 Dec 171010
31 Dec 160-110

Quality Earnings: OSX is currently unprofitable.

Growing Profit Margin: OSX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OSX is unprofitable, and losses have increased over the past 5 years at a rate of 19.3% per year.

Accelerating Growth: Unable to compare OSX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: OSX has a negative Return on Equity (-194.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies